The Ann Arbor Staging System primarily evaluates the spread of lymphoma by considering two main factors: the number of affected lymph node regions and whether the disease has spread beyond the lymph nodes to other organs. It helps in assessing the severity of the disease and is instrumental in treatment planning.
